vaginal ring
Jump to navigation
Jump to search
Indications
- use as hormonal contraceptive
- hormone replacement therapy
- vaginal ring containing dapivirine may be useful for prevention of HIV1[1]
Contraindications
- a contraceptive vaginal ring contains estrogen
- history of breast cancer
- uncontrolled hypertension
- liver disease
- migraine with aura
- smoking > 15 cigarettes/day in women > 35 years
- risk for venous thromboembolism[2]
More general terms
More specific terms
- Estring
- ethinyl estradiol/segesterone acetate (Annovera)
- Femring
- NuvaRing (etonogestrel, ethinyl estradiol)
References
- ↑ 1.0 1.1 Baeten JM, Palanee-Phillips T, Brown ER et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med 2016 Feb 22 <PubMed> PMID: https://pubmed.ncbi.nlm.nih.gov/26900902 Free full text <Internet> http://www.nejm.org/doi/10.1056/NEJMoa1506110
- ↑ 2.0 2.1 Medical Knowledge Self Assessment Program (MKSAP) 20 American College of Physicians, Philadelphia 2025